搜索
Drugs Made In America Acquisition II Ord Shs
DMII添加自选
10.010USD
-0.010-0.10%
收盘 05/08, 16:00（美东）报价延迟15分钟
637.64M总市值
31.77市盈率 TTM
关于 Drugs Made In America Acquisition II Ord Shs 公司
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Ord Shs简介
公司代码DMII
公司名称Drugs Made In America Acquisition II Corp
上市日期Sep 25, 2025
CEOStockwell (Lynn)
员工数量- -
证券类型Ordinary Share
年结日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33301
电话19548703099
网址
公司代码DMII
上市日期Sep 25, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition II Ord Shs公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月19日 周四
更新时间: 2月19日 周四
持股股东
股东类型
持股股东
持股股东
占比
Drugs Made In America Acquisition II LLC
4.64%
Magnetar Capital Partners LP
4.24%
Glazer Capital, LLC
3.69%
First Trust Capital Management L.P.
3.25%
Conaway (Charles C.)
3.14%
其他
81.04%
持股股东
持股股东
占比
Drugs Made In America Acquisition II LLC
4.64%
Magnetar Capital Partners LP
4.24%
Glazer Capital, LLC
3.69%
First Trust Capital Management L.P.
3.25%
Conaway (Charles C.)
3.14%
其他
81.04%
股东类型
持股股东
占比
Hedge Fund
29.83%
Investment Advisor/Hedge Fund
16.78%
Investment Advisor
8.57%
Individual Investor
8.48%
Corporation
6.74%
Pension Fund
2.12%
Research Firm
1.24%
Bank and Trust
0.20%
其他
26.04%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
1
666.67K
0.00%
--
2026Q1
58
37.42M
58.75%
+33.66M
2025Q4
7
3.04M
4.64%
+3.04M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Drugs Made In America Acquisition II LLC
4.83M
7.37%
+4.83M
--
Dec 03, 2025
Magnetar Capital Partners LP
2.70M
4.12%
+2.70M
--
Dec 31, 2025
Glazer Capital, LLC
2.35M
3.58%
+2.35M
--
Dec 31, 2025
First Trust Capital Management L.P.
2.07M
3.15%
+2.07M
--
Dec 31, 2025
Conaway (Charles C.)
2.00M
3.05%
+2.00M
--
Dec 03, 2025
Hudson Bay Capital Management LP
1.97M
3%
+1.97M
--
Dec 31, 2025
Wolverine Asset Management, LLC
1.06M
1.62%
+1.06M
--
Dec 31, 2025
Tenor Capital Management Co., L.P.
1.50M
2.29%
+1.50M
--
Dec 31, 2025
Polar Asset Management Partners Inc.
1.50M
2.29%
+1.50M
--
Dec 31, 2025
Millennium Management LLC
1.50M
2.29%
+1.50M
--
Dec 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
